Search Results for: Advances in Continuous Manufacturing of
Articles
VACCINE TECHNOLOGY - Vaccine Technologies & the Rationale for New Nanoparticle Formulations October 3, 2014
Robert S. Becker, PhD, MBA, and Mark A. Mitchnick, MD, explain how SATx technology provides a new flexible formulation platform for the generation of nanoparticulate vaccine formulations without the limitations of previous formulation technologies that have inhibited the optimization of vaccine potencies and safety profiles.
SPECIAL FEATURE - Injectable Drug Delivery: Safer, Simpler, Smarter Devices September 4, 2014
Contributor Cindy H. Dubin speaks with some of the leading companies operating in the injectables arena, and discovers this ever-evolving sector is witnessing some very specific and eye-opening trends that are affecting the market’s growth.
Capsugel Study Provides First Substantive Reference Data on Key Quality Attributes of Empty Capsules July 28, 2014
Capsugel recently published a study in AAPS’ PharmSciTech journal confirming that Capsugel capsules are suitable excipients for Quality-by-Design (QbD)-based product...SPECIAL FEATURE - Patients & Physicians Desire Transdermal, Topical & Subcutaneous Delivery July 9, 2014
Contributor Cindy H. Dubin recently interviewed several topical, transdermal, and subcutaneous product manufacturers to find out how they are working with patients and physicians to develop delivery systems that meet their needs for comfort, compliance, and more effective delivery.
REGULATORY REVIEW - Regulators Make Intentions Clear on Transparency & Harmonization July 9, 2014
Erick Gaussens says that continued emphasis on data transparency and on streamlining of the submission process – to the benefit of both regulatory agencies and pharma companies – create both opportunities and challenges for companies.
INJECTABLE MICROEMULSIONS - Prolonged-Release Injectable Microemulsions: Opportunities for Pain Treatment June 4, 2014
Rajesh Dubey, PhD, and Luigi G. Martini, FRPharmS, MBA, indicate available technologies do not support development of certain formulations to treat pain; however, microemulsions with their unique features, can provide a viable alternative to develop such formulations.
Noxilizer & Weiler Announce Exclusive Agreement for Blow/Fill/Seal Market April 7, 2014
Noxilizer, Inc., the company advancing a room temperature, NO2-based sterilization process for life science manufacturers, and Weiler Engineering, Inc., a...ADVANCED DELIVERY DEVICES - New Drug Delivery & Stabilization Platforms Gaining Global Interest March 5, 2014
Sam de Costa, PhD, believes the launch of two stabilization and drug delivery platforms that have the potential to revolutionize the delivery of vaccines, therapeutics, and diagnostics, while significantly cutting costs, has attracted sharp interest from pharmaceutical and biotech companies around the world.
BIOAVAILABILITY ENHANCEMENT - Navigating a Broad Spectrum of Solubilization Technologies: Part II of III October 15, 2013
Marshall Crew, PhD, President & CEO, Agere Pharmaceuticals, Inc., continues his multiple-part series discussing today’s most challenging issues in solubility.
11/21/2012 November 19, 2012
Innovative Drugs to Transform Alzheimer's Disease Medication Market The patent expiry of all four existing EMEA-approved drugs for Alzheimer's disease...Intarcia Therapeutics Secures Landmark $210-Million Financing November 19, 2012
Intarcia Therapeutics, Inc. recently announced the simultaneous completion of two financings with total proceeds of $210 million, the largest sum...11/14/2012 November 8, 2012
A Note to The Pharmaceutical Industry Upon The Re-Election of Barack Obama By: Matthew Herper, Forbes Staff, mherper@forbes.com I've covered...Novartis Expects 14 New Blockbusters November 8, 2012
Novartis recently provided an update on its leading Research and Development (R&D) pipeline and plans for turning these assets into...10/24/2012 October 21, 2012
Avantor & Rubicon to Collaborate on Next-Generation Functional Excipients Avantor Performance Materials recently announced it has signed a collaboration...5/30/2012 May 28, 2012
Takeda's MAA Filing Triggers a $10-Million MilestoneFuriex Pharmaceuticals, Inc. recently confirmed that Takeda Global Research & Development Centre (Europe) Ltd....Bend Research Increases Hot-Melt Extrusion Capacity May 28, 2012
Bend Research Inc. recently announced the expansion of its existing hot-melt extrusion (HME) capacity with the addition of an 18-mm...3/27/2012 March 21, 2012
Marinomed's Nasal Spray Achieves Positive Clinical Results Marinomed Biotechnologie GmbH, recently announced that data from a clinical trial for the...3/1/2011 February 27, 2011
Elan & PPD Announce Global Business Relationship in Drug Development Elan, plc and PPD, Inc. recently announced they have formed...
